Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition

Overview of attention for article published in Frontiers in oncology, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 7,930 followers.

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-kappaB Disinhibition by Hongli Liu https://t.co/C6IWmaXErB

21 Feb 2022

Reply Repost Favourite

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-kappaB Disinhibition by Hongli Liu https://t.co/sGK0dbzZkm

20 Feb 2022

Reply Repost Favourite

Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-kappaB Disinhibition by Hongli Liu https://t.co/lBV1a7ruqW

19 Feb 2022

Reply Repost Favourite

New research: Lirilumab and Avelumab Enhance Anti-HPV+ Cervical Cancer Activity of Natural Killer Cells via Vav1-Dependent NF-κB Disinhibition: Background We investigated the efficacy and mechanism of the anti-KIR immunotherapy lirilumab and… https://t.co

31 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.